Leading Insights: A Conversation with Professors Santos and Watts
Watch the first episode of IAS’ new Leading Insights series to hear Prof. Raul Santos and Prof. Gerald Watts discuss the PALISADE study’s findings, noting how plozasiran demonstrated it can meet the treatment gap for patients with familial chylomicronemia syndrome whether the rare disease is clinically defined or genetically confirmed.
IAS received an unrestricted grant from Arrowhead Pharmaceuticals to help produce this resource.
About Leading Insights
Leading Insights is a new video series in which IAS’ global experts discuss recent research findings about breakthrough therapies or devices relevant to the treatment or management of atherosclerosis or related cardiometabolic diseases.
Promoting the scientific understanding of atherosclerosis
Newsletters
-
The IAS e-Newsletter is a digest of the latest from the IAS and its Constituent Member Societies.
-
Going beyond statins, this resource provides the latest information about primary prevention for clinicians.
